Crossmark

Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients

Crossref DOI link: https://doi.org/10.1186/s13046-015-0152-7

Published Online: 2015-05-19

Published Print: 2015-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Heublein, Sabine

Mayr, Doris

Egger, Markus

Karsten, Uwe

Goletz, Steffen

Angele, Martin

Gallwas, Julia

Jeschke, Udo

Ditsch, Nina
License Information

License valid from 2015-05-19
More Information

Article History

Received: 3 December 2014

Accepted: 1 April 2015

First Online: 19 May 2015